| Net income (loss) | -2.36B |
| Depreciation, depletion, and amortization | 3.2B |
| Deferred income taxes | -1.12B |
| Dry hole expense and impairments of unproved properties | |
| Impairments | 61M |
| (Gains) losses on divestitures, net | |
| Unrealized (gains) losses on derivatives, net | |
| Other | 256M |
| (Increase) decrease in accounts receivable | |
| Increase (decrease) in accounts payable and accrued expenses | -833M |
| Other items - net | 55M |
| Net cash provided by (used in) operating activities | 1.88B |
| Additions to properties and equipment and dry hole costs | -2.62B |
| Acquisition of midstream businesses | |
| Divestitures of properties and equipment and other assets | |
| Other - net | 81M |
| Net cash provided by (used in) investing activities | -1.26B |
| Borrowings, net of issuance costs | |
| Repayments of debt | |
| Repayment of midstream subsidiary note payable to a related party | |
| Increase (decrease) in accounts payable, banks | -126M |
| Dividends paid | -78M |
| Repurchase of common stock | |
| Issuance of common stock, including tax benefit on stock option exercises | |
| Sale of subsidiary units | |
| Distributions to noncontrolling interest owners | |
| Other financing activities | 413M |
| Net cash provided by (used in) financing activities | 2.42B |
| Effect of Exchange Rate Changes on Cash | -1M |
| Net Increase (Decrease) in Cash and Cash Equivalents | 3.04B |
| Cash and Cash Equivalents at Beginning of Period | 939M |
| Cash and Cash Equivalents at End of Period | 3.98B |